Statin use in resected, high-risk cutaneous melanoma: A multi-centre retrospective cohort study
Background: Pre-clinical and clinical studies propose that statins may have chemopreventive effects against cancer, suggesting their possible roles as adjunctive therapies for melanoma. Objective: To investigate the association between regular statin use and disease recurrence in patients with resec...
Saved in:
| Main Authors: | Charlie Yue Wang, Mark Shackleton, Sonia Mailer, Grant A. McArthur, Sophia Zoungas, Rory Wolfe, Victoria J. Mar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | EJC Skin Cancer |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772611824000016 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers
by: Pedro Gabriel Senger Braga, et al.
Published: (2024-11-01) -
Adjuvant and neoadjuvant immunotherapy for acral and mucosal melanoma
by: Takaya Komori, et al.
Published: (2025-01-01) -
Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins
by: Zhuangqi Shi, et al.
Published: (2025-01-01) -
Hepatotoxicity of statins: a real-world study based on the US Food and Drug Administration Adverse Event Reporting System database
by: Bojing Wang, et al.
Published: (2025-01-01) -
Real-World efficiency of pembrolizumab in metastatic melanoma patients following adjuvant anti-PD1 treatment
by: Michael Weichenthal, et al.
Published: (2024-12-01)